New Study Shows Novel Transdermal Curcumin Significantly Benefits Cardiac Function in Sickle Cell Disease A groundbreaking study from Vascarta Inc. shows that VAS-101, a transdermal curcumin, improves cardiac mitochondrial function in sickle cell disease, potentially changing treatment paradigms.

New Study Shows Novel Transdermal Curcumin Significantly Benefits Cardiac Function in Sickle Cell Disease #United_States #Sickle_Cell #VAS-101 #Summit #transdermal_curcumin